Mitoxantrone for the treatment of advanced breast cancer: Single-agent therapy in previously untreated patients
- 1 September 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (9) , 1141-1146
- https://doi.org/10.1016/0277-5379(84)90122-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- SAFETY ASSESSMENT OF A NEW ANTICANCER COMPOUND, MITOXANTRONE, IN BEAGLE DOGS - COMPARISON WITH DOXORUBICIN .2. HISTOLOGIC AND ULTRASTRUCTURAL PATHOLOGY1982
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- ACTIVITY OF A NOVEL ANTHRACENEDIONE, 1,4-DIHYDROXY-5,8-BIS[[[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]]-9,10-ANTHRACENEDIONE DIHYDROCHLORIDE, AGAINST EXPERIMENTAL-TUMORS IN MICE1979
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976
- Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma.A southwest cancer chemotherapy study group studyCancer, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958